
CPHI Korea 2026
08/2026 – 08/2026
A CDMO specializing in hybrid formulations that combine natural products with synthetic drugs, Benaturebiolab uses proprietary HME-DDS technology to enhance bioavailability and enable precise control over drug release profiles for pharmaceuticals, functional foods and cosmeceuticals, providing development support from formulation through production.

Aucun commentaire disponible.
Laissez votre note & commentaire